|
02.09.2010 |
MorphoSys Initiates Program Against Drug-Resistant MRSA Infections |
 |
|
01.09.2010 |
MorphoSys to Present at Three Investor Conferences in September |
|
|
02.08.2010 |
MorphoSys Announces Clinical Milestone from Strategic Alliance |
|
|
28.07.2010 |
MorphoSys AG Reports Six Months 2010 Results |
|
|
26.07.2010 |
AbD Serotec Secures Exclusive Worldwide License to Key Diagnostic Antibody |
|
|
06.07.2010 |
MorphoSys Receives Research Grant to Advance Anti-CD38 Cancer Program MOR202 and Explore Relevant Biomarkers |
|
|
01.07.2010 |
MorphoSys Announces Clinical Milestone from Strategic Alliance |
|
|
27.06.2010 |
MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program |
|
|
22.06.2010 |
MorphoSys Announces Clinical Milestone |
|
|
25.05.2010 |
MorphoSys's Annual General Meeting Approves All Agenda Items |
|
|
18.05.2010 |
AbD Serotec Enters New Growth Area |
|
|
27.04.2010 |
MorphoSys AG Reports Results for the First Quarter of 2010 |
|
